<DOC>
	<DOCNO>NCT00660595</DOCNO>
	<brief_summary>This pilot trial Finland design evaluate randomize fashion change agitation acute schizophrenic patient ( Schizophrenia Schizoaffective psychosis Schizophreniformic psychosis ) Diagnostic Statistical Manual ( DSM - IV ) first visit day 1 , 2 , 4 5 7 ± 1 .</brief_summary>
	<brief_title>Study Schizophrenic In-patients Treated With Quetiapine Prolong Oral Risperidone Flexible Dose</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>In opinion Investigator , requirement treatment acute episode schizophrenia , schizoaffective disorder schizophreniformic psychosis ( accord DSMIV diagnostic criterion ) , Positive Negative Symptoms Scale ( PANSS ) ≥ 65 , CGI ≥ 4 Pregnancy lactation Inpatients/hospitalized &gt; 7 day enrollment Known intolerance lack response quetiapine fumarate risperidone , judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective psychosis</keyword>
	<keyword>Schizophreniformic psychosis</keyword>
	<keyword>Pilot study</keyword>
	<keyword>Quetiapine Prolong</keyword>
	<keyword>Risperidone</keyword>
</DOC>